openPR Logo
Press release

Peptide Based Infection Therapeutics Market Forecast for Incremental CAGR Growth by 2022

01-15-2018 08:43 AM CET | Health & Medicine

Press release from: Fact.MR

Fact.MR

Fact.MR

Fact.MR has recently added a new report to its vast online database. This research study is titled as “Peptide Based Infection Therapeutics Market Report” which presents an in-depth study about the production, consumption, market volume, revenue (million USD) and market share across different geographical regions.

Request For Sample Report
@ https://www.factmr.com/connectus/sample?flag=S&rep_id=188

There is a need to develop novel therapeutic agents in order to fight infections. Peptide therapeutics are used to fight infectious diseases. The global peptide based infection therapeutics market is expected to grow in the future owing to factors such as cost effectiveness of peptides, higher efficacy of peptides in managing various disease indications and infections, and can be easily synthesized owing to smaller size. Moreover, few economic factors such as government policies for startup companies, increasing foreign direct investment, as well as higher investment in healthcare are also driving the global peptide based infection therapeutics market. The rising prevalence of infectious diseases has resulted in providing an impetus to the use of peptides therapeutics to treat infections. Along with this, emerging biotech and pharmaceutical companies, strong and advanced pipelines and patent expiries are few other aspects impacting the growth of the global peptide based infection therapeutics market positively. To support this, the advancements in technology and increased research and development and the rising investments in these fields have led to the growing importance of global peptide based infection therapeutics market. North America is expected to show higher attractiveness in this market.

Peptide therapeutics are stable, safe, tolerable, possess selective nature, and effective. They are used in the treatment of infections owing to their broad spectrum of activities and mechanisms. They protect the host from pathogenic microbes and are also referred to as host defense peptides owing to their functionality in protecting the immunity system and fighting against infections.

6 Forecast Highlights on Global Peptide Based Infection Therapeutics Market

1) North America expected to show higher market attractiveness and domination over other regions in terms of market share by revenue. It has a higher value share and is poised to grow at a higher growth rate to reflect a CAGR of 8.4% throughout the forecast period, 2017 to 2022
2) Asia-Pacific excluding Japan (APEJ) shows the highest growth rate and poised to register a CAGR of 8.7% during the period of forecast, owing to rapid development and higher foreign direct investment in this region. Following APEJ, Europe region also reflects good rate of growth in the global peptide based infection therapeutics market
3) By drug class, telaprivir shows higher market share by revenue as compared to boceprevir. However, boceprivir shows a higher growth rate to reflect a CAGR of 8.2% during the period of forecast. It can be said that, even though telaprevir segment has a market share which is almost one and a half times than that of boceprevir, the boseprivir segment, could match the market share at this high growth rate post 2022, a market observation which would depend on the current growth rate of boceprivir and its consistency through 2017 to 2022 and even beyond
4) The online pharmacies segment by distribution channel shows the fastest growth rate and is poised to reflect a CAGR of 9.2% throughout the period of forecast of 2017 to 2022. Yet, this segment shows less market share by revenue as compared to other segments.
5) The hospital pharmacy segment enjoys the highest market revenue share followed by retail pharmacy segment. The retail pharmacy segment, however, reflects a higher growth rate as compared to the hospital pharmacy segment. It would be only appropriate to track these two segments who have a toe to toe competition, in order to check the scenarios by the end of 2022
6) The online pharmacies segment finds North America region to be the most lucrative and has the highest growth in this region comparatively. The APEJ region is much favorable for the hospital and retail pharmacies segment followed by Europe. Latin America and Middle East and Africa region show less attractiveness comparatively

Browse Full Report with TOC @ https://www.factmr.com/report/188/peptide-based-infection-therapeutics-market

APEJ to Show Tremendous Activity as Compared to Europe
The Asia-Pacific excluding Japan (APEJ) region is expected to show a rapid growth rate and is expected to register a CAGR of 8.7% during the period of forecast. The main reasons for this kind of growth is the strict government regulations for the upcoming players, higher number of pharmaceutical companies, increased foreign direct investment and development of technologies. Moreover, the government encourages to increase the investment in the healthcare industry to discover and invent new methods and technologies to better the health of the patients and enhance patient outcome. Following Asia-Pacific excluding Japan (APEJ) region, Europe regions also shows good growth rate in the global peptide based infection therapeutics market.

Online Pharmacies to Show Robust Growth Rate, Would Just be an Understatement
The online pharmacies segment by distribution channel is anticipated to show exponential growth rate to register a CAGR of 9.2% throughout the period of forecast, 2017 to 2022. This growth can be attributed towards the increasing awareness of the online concept, its effectiveness, reliability and convenience. However, this segment, still being in its nascent phase, has less market share as compared to other segments in the distribution channel category. The online segment is also expected to experience a higher gain in the BPS by the end of 2022. The online pharmacies segment reflects the highest growth in the North America region rate as compared to other regions during the period of forecast.

Hospital vs. Retail Pharmacies, a Touch Call to Make
Hospital pharmacies segment enjoys the highest market share by revenue thereby dominating the global market, as per market observations in 2016 and 2017. This trend could keep up with the growth rate that it reflects. However, the retail pharmacies segment shows a higher growth rate, yet less market share. It is anticipated to reflect a higher growth rate and poised to register a CAGR of 7.9% during the period of forecast of 2017 to 2022. The regions favoring the growth of the hospital pharmacy segment is APEJ followed by Europe. APEJ is also favorable for retail pharmacies segment, in fact the growth of retail pharmacies in this region is the highest as compared to other regions, as per anticipations. Asia-Pacific excluding Japan expected to stay strong with respect to all the segments by distribution channel, except for the online pharmacies segment which finds better shelter in North America region.

Competition Tracking
The report also profiles companies that are expected to remain active in the expansion of the global peptide based infection therapeutics market through 2022, which include Vertex Pharmaceuticals Incorporated, Merck & Co., Inc. and Parchem Fine & Specialty Chemicals.

Check Discount @ https://www.factmr.com/connectus/sample?flag=D&rep_id=188

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Peptide Based Infection Therapeutics Market Forecast for Incremental CAGR Growth by 2022 here

News-ID: 899205 • Views:

More Releases from Fact.MR

Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
The latest report on the Bioinformatics Market, projecting robust growth driven by the increasing demand for genomic research, advancements in artificial intelligence (AI), and the rising adoption of precision medicine. Valued at USD 14.29 billion in 2024, the global market is forecast to expand at a compound annual growth rate (CAGR) of 13.4%, reaching USD 50.25 billion by 2034. This significant growth underscores the critical role of bioinformatics in decoding
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Key Players: iRobot Corporation, Neato Robotics, Inc., Yujin Robot, Co., Ltd., and Dyson Inc
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Ke …
Fact.MR today released its latest report on the Residential Robotic Vacuum Cleaner Market, projecting robust growth driven by increasing demand for automation, busy lifestyles, and advancements in smart home technologies. Valued at USD 3.0 billion in 2023, the global market is forecast to expand at a compound annual growth rate (CAGR) of 14.4%, reaching USD 11.6 billion by 2033. This significant growth highlights the rising adoption of robotic vacuum cleaners
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
08-29-2025 | Health & Medicine
Fact.MR
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
The global brain-computer interface (BCI) market was valued at USD 1.6 billion in 2022 and is projected to reach USD 6.5 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2023 to 2033. This expansion reflects the increasing adoption of BCI technologies in medical applications, driven by advancements in neuroscience, AI, and sensor technologies. BCIs enable direct communication between the brain and external devices, offering
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2034 | Key Players: Johnson & Johnson Services Inc; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd.; Takeda Pharmaceutical Company Limited
08-29-2025 | Health & Medicine
Fact.MR
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2 …
The global orally disintegrating tablet (ODT) market is valued at USD 24.45 billion in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 11.5%, reaching USD 72.68 billion by 2034. This robust growth is driven by the increasing demand for patient-friendly dosage forms, particularly among the elderly, pediatric, and dysphagic populations, who benefit from ODTs' ease of administration without water and rapid dissolution. ODTs enhance

All 5 Releases


More Releases for APEJ

APEJ to Spearhead the Global Soy Protein Hydrolysate by 2026
The Global Dietary Supplements Industry Current Scenario and Outlook The unprecedented COVID-19 outbreak has brought significant challenges for various industries across the globe. Stringent restrictions on movement, production, supply of raw materials, and limited stocks have affected the growth of businesses to a great extent.However, with the roll out of the vaccination process in countries like the U.S., the U.K., China, India, and Germany, manufacturers are gaining momentum in terms of
Lacquer Market : APEJ to be the largest market through 2028
Global demand for lacquers is likely to reach roughly 7 million tons in 2018, as applications in furniture, automotive, and architectural industries create sustained growth opportunities. The shift from solvent-based to water-based lacquers will become more palpable in the next decade, as a combination of environmental compliance and end-user consciousness induces changes in manufacturing and uptake. The long-term outlook on lacquer market remains bullish, with novel applications in cosmetics likely
Dimethylolpropionic Acid (DMPA) Market: APEJ to Remain Largest Consuming
Future Market Insights (FMI) delivers key insights on the global dimethylolpropionic acid market in its upcoming report titled “Dimethylolpropionic Acid (DMPA) Market: Global Industry Analysis and Opportunity Assessment 2015–2020”. The global Dimethylolpropionic Acid (DMPA) market is projected to expand at a CAGR of over 8% during the forecast period (2015–2020), largely due to increasing demand for polyurethane dispersions, regarding which FMI offers vital insights in detail in this report. On the
Global Construction Polymer Manufacturing to Remain Concentred in the APEJ Regio …
Over the years, the global construction industry has emerged as the largest consumer of polymer composites. Surging use of polymer and polymer composite materials in the construction industry has been instrumented by the technical, structural, architectural, and designing advantages of construction polymers over conventional construction materials such as dust, sand and concrete. Future Market Insights’ new report reveals that by the end of 2026, over US$ 135 Mn worth of
APEJ Automotive Aftermarket to hit US$ 218.73 Bn by 2025
Future Market Insights (FMI) announces release of its latest market outlook forecast titled “Automotive Aftermarket: Asia-Pacific Excl. Japan (APEJ) Industry Analysis and Opportunity Assessment 2015 - 2025”. According to this report, automotive aftermarket components in Asia Pacific is anticipated to account for US$ 218.73 Bn by 2025, registering a compound annual growth rate (CAGR) of 9.1% throughout the forecast period. The automotive aftermarket is a secondary market, which plays a
APEJ Automotive Aftermarket Poised to hit US$ 218.73 Bn by 2025
Future Market Insights (FMI) announces release of its latest market outlook forecast titled “Automotive Aftermarket: Asia-Pacific Excl. Japan (APEJ) Industry Analysis and Opportunity Assessment 2015 - 2025”. According to this report, automotive aftermarket components in Asia Pacific is anticipated to account for US$ 218.73 Bn by 2025, registering a compound annual growth rate (CAGR) of 9.1% throughout the forecast period. The automotive aftermarket is a secondary market, which plays a